MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. (Q41235761)
Jump to navigation
Jump to search
scientific article published on February 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation. |
scientific article published on February 1996 |
Statements
MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation (English)
Shishido
K Koya
Y Li
H Wang
T Ukai
N Tatsuta
M Kawakami
1 February 1996